Severe Left Ventricular Dysfunction Secondary to Primary Pulmonary Hypertension: Bridging Therapy With Bosentan Before Lung Transplantation
- 1 June 2005
- journal article
- case report
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (6) , 777-780
- https://doi.org/10.1016/j.healun.2004.02.020
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertensionPublished by Elsevier ,2003
- Bosentan Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2002
- Lung and heart-lung transplant practice patterns in pulmonary hypertension centersThe Journal of Heart and Lung Transplantation, 2001
- Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?Journal of the American College of Cardiology, 2001
- Pathophysiology of Impaired Right and Left Ventricular Function in Chronic Embolic Pulmonary HypertensionChest, 2000
- Pressure and Volume Loading of the Right Ventricle Have Opposite Effects on Left Ventricular Ejection FractionCirculation, 1995
- Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantationJournal of the American College of Cardiology, 1993
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991
- LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)The Lancet, 1984